Capital World Investors’s Vertex Pharmaceuticals VRTX Stock Holding History

Capital World Investors’s Portfolio VRTX Stock Details VRTX Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$12.8B	Buy	28,732,143 +198,835	+0.7%	+$88.5M	1.86%	9
2025 Q1	$13.8B	Buy	28,533,308 +207,613	+0.7%	+$101M	2.24%	7
2024 Q4	$11.4B	Buy	28,325,695 +1,514,993	+6%	+$610M	1.73%	9
2024 Q3	$12.5B	Buy	26,810,702 +102,736	+0.4%	+$47.8M	1.93%	8
2024 Q2	$12.5B	Buy	26,707,966 +1,140,782	+4%	+$535M	2.04%	7
2024 Q1	$10.7B	Buy	25,567,184 +3,761,414	+17%	+$1.57B	1.77%	8
2023 Q4	$8.87B	Buy	21,805,770 +3,824,103	+21%	+$1.56B	1.58%	10
2023 Q3	$6.25B	Buy	17,981,667 +641,033	+4%	+$223M	1.24%	13
2023 Q2	$6.1B	Buy	17,340,634 +1,196,211	+7%	+$421M	1.17%	15
2023 Q1	$5.09B	Buy	16,144,423 +3,375,417	+26%	+$1.06B	1.05%	18
2022 Q4	$3.69B	Buy	12,769,006 +244,327	+2%	+$70.6M	0.79%	27
2022 Q3	$3.63B	Sell	12,524,679 -45,253	-0.4%	-$13.1M	0.81%	23
2022 Q2	$3.54B	Sell	12,569,932 -96,198	-0.8%	-$27.1M	0.75%	25
2022 Q1	$3.31B	Buy	12,666,130 +1,145,275	+10%	+$299M	0.57%	38
2021 Q4	$2.53B	Buy	11,520,855 +478,553	+4%	+$105M	0.4%	59
2021 Q3	$2B	Buy	11,042,302 +26,924	+0.2%	+$4.88M	0.34%	75
2021 Q2	$2.22B	Buy	11,015,378 +1,357,903	+14%	+$274M	0.38%	70
2021 Q1	$2.08B	Buy	9,657,475 +3,320	+0%	+$713K	0.38%	66
2020 Q4	$2.28B	Sell	9,654,155 -1,706,360	-15%	-$403M	0.44%	54
2020 Q3	$3.09B	Sell	11,360,515 -1,127,728	-9%	-$307M	0.68%	33
2020 Q2	$3.63B	Sell	12,488,243 -91,475	-0.7%	-$26.6M	0.88%	23
2020 Q1	$2.99B	Buy	12,579,718 +1,981,607	+19%	+$472M	0.87%	28
2019 Q4	$2.32B	Buy	10,598,111 +11,278	+0.1%	+$2.47M	0.52%	49
2019 Q3	$1.79B	Sell	10,586,833 -862,721	-8%	-$146M	0.43%	68
2019 Q2	$2.1B	Buy	11,449,554 +535,827	+5%	+$98.3M	0.49%	54
2019 Q1	$2.01B	Buy	10,913,727 +1,033,361	+10%	+$190M	0.49%	56
2018 Q4	$1.64B	Buy	9,880,366 +2,181,475	+28%	+$361M	0.44%	60
2018 Q3	$1.48B	Sell	7,698,891 -3,293,143	-30%	-$635M	0.36%	74
2018 Q2	$1.87B	Buy	10,992,034 +1,993,107	+22%	+$339M	0.4%	65
2018 Q1	$1.47B	Buy	8,998,927 +3,109,444	+53%	+$507M	0.33%	84
2017 Q4	$883M	Sell	5,889,483 -5,672,358	-49%	-$850M	0.19%	123
2017 Q3	$1.76B	Sell	11,561,841 -3,854,581	-25%	-$586M	0.4%	67
2017 Q2	$1.99B	Sell	15,416,422 -2,484,511	-14%	-$320M	0.47%	59
2017 Q1	$1.96B	Sell	17,900,933 -2,857,200	-14%	-$312M	0.47%	60
2016 Q4	$1.53B	Sell	20,758,133 -1,534,250	-7%	-$113M	0.38%	69
2016 Q3	$1.94B	Buy	22,292,383 +599,586	+3%	+$52.3M	0.51%	51
2016 Q2	$1.87B	Buy	21,692,797 +94,635	+0.4%	+$8.14M	0.5%	51
2016 Q1	$1.72B	Buy	21,598,162 +860,251	+4%	+$68.4M	0.47%	52
2015 Q4	$2.61B	Sell	20,737,911 -174,194	-0.8%	-$21.9M	0.73%	31
2015 Q3	$2.18B	Sell	20,912,105 -1,109,315	-5%	-$116M	0.64%	39
2015 Q2	$2.72B	Sell	22,021,420 -1,427,057	-6%	-$176M	0.74%	38
2015 Q1	$2.77B	Sell	23,448,477 -1,160,000	-5%	-$137M	0.75%	36
2014 Q4	$2.92B	Sell	24,608,477 -1,048,700	-4%	-$125M	0.79%	35
2014 Q3	$2.88B	Sell	25,657,177 -725,000	-3%	-$81.4M	0.81%	31
2014 Q2	$2.5B	Sell	26,382,177 -357,500	-1%	-$33.8M	0.69%	39
2014 Q1	$1.89B	Buy	26,739,677 +1,222,800	+5%	+$86.5M	0.54%	52
2013 Q4	$1.9B	Buy	25,516,877 +497,000	+2%	+$36.9M	0.53%	47
2013 Q3	$1.9B	Buy	25,019,877 +1,068,200	+4%	+$81M	0.58%	46
2013 Q2	$1.91B	Buy	+23,951,677	New	+$1.91B	0.62%	42